共 50 条
- [31] A Phase I Study of Cixutumumab (IMC-A12) in Combination with Temsirolimus (CCI-779) in Children with Recurrent Solid Tumors: AChildren's Oncology Group Phase I Consortium ReportCLINICAL CANCER RESEARCH, 2015, 21 (07) : 1558 - 1565Fouladi, Maryam论文数: 0 引用数: 0 h-index: 0机构: Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USAPerentesis, John P.论文数: 0 引用数: 0 h-index: 0机构: Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USAWagner, Lars M.论文数: 0 引用数: 0 h-index: 0机构: Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USAVinks, Alexander A.论文数: 0 引用数: 0 h-index: 0机构: Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USAReid, Joel M.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Coll Med, Rochester, MN USA Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USAAhern, Charlotte论文数: 0 引用数: 0 h-index: 0机构: Childrens Oncol Grp Operat Ctr, Arcadia, CA USA Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USAThomas, George论文数: 0 引用数: 0 h-index: 0机构: Univ Cincinnati, Cincinnati, OH USA Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USAMercer, Carol A.论文数: 0 引用数: 0 h-index: 0机构: Univ Cincinnati, Cincinnati, OH USA Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USAKrueger, Darcy A.论文数: 0 引用数: 0 h-index: 0机构: Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USAHoughton, Peter J.论文数: 0 引用数: 0 h-index: 0机构: Nationwide Childrens Hosp, Columbus, OH USA Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USADoyle, L. Austin论文数: 0 引用数: 0 h-index: 0机构: NCI, Canc Therapy Evaluat Program, Bethesda, MD USA Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USAChen, Helen论文数: 0 引用数: 0 h-index: 0机构: NCI, Canc Therapy Evaluat Program, Bethesda, MD USA Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USAWeigel, Brenda论文数: 0 引用数: 0 h-index: 0机构: Univ Minnesota, Minneapolis, MN USA Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USABlaney, Susan M.论文数: 0 引用数: 0 h-index: 0机构: Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
- [32] Final results of a phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphomaANNALS OF ONCOLOGY, 2005, 16 : 65 - 65Witzig, T论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USAGeyer, S论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USAGhobrial, I论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USAInwards, D论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USAFonseca, R论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USAKurtin, P论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USAAnsell, S论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USAKaufmann, S论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USA
- [33] FEASIBILITY/TOLERABILITY RESULTS FROM A PHASE I/II STUDY OF TEMSIROLIMUS (CCI-779) AND SORAFENIB IN RECURRENT GLIOBLASTOMA: NORTH CENTRAL CANCER TREATMENT GROUP (NCCTG) N0572NEURO-ONCOLOGY, 2009, 11 (02) : 232 - 232Schiff, David论文数: 0 引用数: 0 h-index: 0机构: Univ Virginia, Neurooncol Ctr, Charlottesville, VA USA Univ Virginia, Neurooncol Ctr, Charlottesville, VA USASarkaria, Jann论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USA Univ Virginia, Neurooncol Ctr, Charlottesville, VA USADecker, Paul论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USA Univ Virginia, Neurooncol Ctr, Charlottesville, VA USABuckner, Jan论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USA Univ Virginia, Neurooncol Ctr, Charlottesville, VA USAGalanis, Evanthia论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USA Univ Virginia, Neurooncol Ctr, Charlottesville, VA USADancey, Janet论文数: 0 引用数: 0 h-index: 0机构: NCI, Bethesda, MD 20892 USA Univ Virginia, Neurooncol Ctr, Charlottesville, VA USAGiannini, Caterina论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USA Univ Virginia, Neurooncol Ctr, Charlottesville, VA USABrown, Paul论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USA Univ Virginia, Neurooncol Ctr, Charlottesville, VA USAWiesenfeld, Martin论文数: 0 引用数: 0 h-index: 0机构: Cedar Rapids Oncol Project CCOP, Cedar Rapids, IA USA Univ Virginia, Neurooncol Ctr, Charlottesville, VA USAJaeckle, Kurt论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USA Univ Virginia, Neurooncol Ctr, Charlottesville, VA USA
- [34] Phase II study of bevacizumab plus erlotinib for recurrent malignant gliomasJOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)论文数: 引用数: h-index:机构:Desjardins, A.论文数: 0 引用数: 0 h-index: 0机构: Duke Univ, Med Ctr, Durham, NC USA Duke Univ, Med Ctr, Durham, NC USAVredenburgh, J. J.论文数: 0 引用数: 0 h-index: 0机构: Duke Univ, Med Ctr, Durham, NC USA Duke Univ, Med Ctr, Durham, NC USARich, J. N.论文数: 0 引用数: 0 h-index: 0机构: Duke Univ, Med Ctr, Durham, NC USA Duke Univ, Med Ctr, Durham, NC USAGururangan, S.论文数: 0 引用数: 0 h-index: 0机构: Duke Univ, Med Ctr, Durham, NC USA Duke Univ, Med Ctr, Durham, NC USAFriedman, A. H.论文数: 0 引用数: 0 h-index: 0机构: Duke Univ, Med Ctr, Durham, NC USA Duke Univ, Med Ctr, Durham, NC USAFriedman, H. S.论文数: 0 引用数: 0 h-index: 0机构: Duke Univ, Med Ctr, Durham, NC USA Duke Univ, Med Ctr, Durham, NC USAReardon, D. A.论文数: 0 引用数: 0 h-index: 0机构: Duke Univ, Med Ctr, Durham, NC USA Duke Univ, Med Ctr, Durham, NC USA
- [35] Phase I/II study of imatinib mesylate (STI571) for patients with recurrent malignant gliomas (NABTC 99-08)NEURO-ONCOLOGY, 2004, 6 (04) : 385 - 385Wen, PY论文数: 0 引用数: 0 h-index: 0机构: Univ Texas, MD Anderson Canc Ctr, N Amer Brain Tumor Consortium, Houston, TX 77030 USAYung, WKA论文数: 0 引用数: 0 h-index: 0机构: Univ Texas, MD Anderson Canc Ctr, N Amer Brain Tumor Consortium, Houston, TX 77030 USALamborn, K论文数: 0 引用数: 0 h-index: 0机构: Univ Texas, MD Anderson Canc Ctr, N Amer Brain Tumor Consortium, Houston, TX 77030 USAPeng, B论文数: 0 引用数: 0 h-index: 0机构: Univ Texas, MD Anderson Canc Ctr, N Amer Brain Tumor Consortium, Houston, TX 77030 USADahia, P论文数: 0 引用数: 0 h-index: 0机构: Univ Texas, MD Anderson Canc Ctr, N Amer Brain Tumor Consortium, Houston, TX 77030 USAAbrey, L论文数: 0 引用数: 0 h-index: 0机构: Univ Texas, MD Anderson Canc Ctr, N Amer Brain Tumor Consortium, Houston, TX 77030 USARaiser, J论文数: 0 引用数: 0 h-index: 0机构: Univ Texas, MD Anderson Canc Ctr, N Amer Brain Tumor Consortium, Houston, TX 77030 USACloughesy, T论文数: 0 引用数: 0 h-index: 0机构: Univ Texas, MD Anderson Canc Ctr, N Amer Brain Tumor Consortium, Houston, TX 77030 USAFink, K论文数: 0 引用数: 0 h-index: 0机构: Univ Texas, MD Anderson Canc Ctr, N Amer Brain Tumor Consortium, Houston, TX 77030 USAGilbert, M论文数: 0 引用数: 0 h-index: 0机构: Univ Texas, MD Anderson Canc Ctr, N Amer Brain Tumor Consortium, Houston, TX 77030 USAChang, S论文数: 0 引用数: 0 h-index: 0机构: Univ Texas, MD Anderson Canc Ctr, N Amer Brain Tumor Consortium, Houston, TX 77030 USAJunck, L论文数: 0 引用数: 0 h-index: 0机构: Univ Texas, MD Anderson Canc Ctr, N Amer Brain Tumor Consortium, Houston, TX 77030 USASchiff, D论文数: 0 引用数: 0 h-index: 0机构: Univ Texas, MD Anderson Canc Ctr, N Amer Brain Tumor Consortium, Houston, TX 77030 USALieberman, F论文数: 0 引用数: 0 h-index: 0机构: Univ Texas, MD Anderson Canc Ctr, N Amer Brain Tumor Consortium, Houston, TX 77030 USAFine, H论文数: 0 引用数: 0 h-index: 0机构: Univ Texas, MD Anderson Canc Ctr, N Amer Brain Tumor Consortium, Houston, TX 77030 USAMehta, M论文数: 0 引用数: 0 h-index: 0机构: Univ Texas, MD Anderson Canc Ctr, N Amer Brain Tumor Consortium, Houston, TX 77030 USARobins, HI论文数: 0 引用数: 0 h-index: 0机构: Univ Texas, MD Anderson Canc Ctr, N Amer Brain Tumor Consortium, Houston, TX 77030 USADeAngelis, LM论文数: 0 引用数: 0 h-index: 0机构: Univ Texas, MD Anderson Canc Ctr, N Amer Brain Tumor Consortium, Houston, TX 77030 USAHess, K论文数: 0 引用数: 0 h-index: 0机构: Univ Texas, MD Anderson Canc Ctr, N Amer Brain Tumor Consortium, Houston, TX 77030 USAGroves, M论文数: 0 引用数: 0 h-index: 0机构: Univ Texas, MD Anderson Canc Ctr, N Amer Brain Tumor Consortium, Houston, TX 77030 USAPuduvalli, VK论文数: 0 引用数: 0 h-index: 0机构: Univ Texas, MD Anderson Canc Ctr, N Amer Brain Tumor Consortium, Houston, TX 77030 USALevin, V论文数: 0 引用数: 0 h-index: 0机构: Univ Texas, MD Anderson Canc Ctr, N Amer Brain Tumor Consortium, Houston, TX 77030 USAConrad, C论文数: 0 引用数: 0 h-index: 0机构: Univ Texas, MD Anderson Canc Ctr, N Amer Brain Tumor Consortium, Houston, TX 77030 USAKuhn, J论文数: 0 引用数: 0 h-index: 0机构: Univ Texas, MD Anderson Canc Ctr, N Amer Brain Tumor Consortium, Houston, TX 77030 USAMaher, E论文数: 0 引用数: 0 h-index: 0机构: Univ Texas, MD Anderson Canc Ctr, N Amer Brain Tumor Consortium, Houston, TX 77030 USAHayes, M论文数: 0 引用数: 0 h-index: 0机构: Univ Texas, MD Anderson Canc Ctr, N Amer Brain Tumor Consortium, Houston, TX 77030 USASilberman, S论文数: 0 引用数: 0 h-index: 0机构: Univ Texas, MD Anderson Canc Ctr, N Amer Brain Tumor Consortium, Houston, TX 77030 USALetvak, L论文数: 0 引用数: 0 h-index: 0机构: Univ Texas, MD Anderson Canc Ctr, N Amer Brain Tumor Consortium, Houston, TX 77030 USACapdeville, R论文数: 0 引用数: 0 h-index: 0机构: Univ Texas, MD Anderson Canc Ctr, N Amer Brain Tumor Consortium, Houston, TX 77030 USAKaplan, R论文数: 0 引用数: 0 h-index: 0机构: Univ Texas, MD Anderson Canc Ctr, N Amer Brain Tumor Consortium, Houston, TX 77030 USAMurgo, A论文数: 0 引用数: 0 h-index: 0机构: Univ Texas, MD Anderson Canc Ctr, N Amer Brain Tumor Consortium, Houston, TX 77030 USAStiles, C论文数: 0 引用数: 0 h-index: 0机构: Univ Texas, MD Anderson Canc Ctr, N Amer Brain Tumor Consortium, Houston, TX 77030 USAPrados, MD论文数: 0 引用数: 0 h-index: 0机构: Univ Texas, MD Anderson Canc Ctr, N Amer Brain Tumor Consortium, Houston, TX 77030 USA
- [36] A Phase 2 Study of Temsirolimus (CCI-779) in Patients With Soft Tissue Sarcomas A Study of the Mayo Phase 2 Consortium (P2C)CANCER, 2011, 117 (15) : 3468 - 3475Okuno, Scott论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Coll Med, Dept Oncol, Rochester, MN 55905 USA Mayo Clin, Coll Med, Dept Oncol, Rochester, MN 55905 USABailey, Howard论文数: 0 引用数: 0 h-index: 0机构: Univ Wisconsin, Div Oncol, Ctr Comprehens Canc, Madison, WI USA Mayo Clin, Coll Med, Dept Oncol, Rochester, MN 55905 USAMahoney, Michelle R.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Coll Med, Dept Oncol, Rochester, MN 55905 USA Mayo Clin, Coll Med, Dept Oncol, Rochester, MN 55905 USA论文数: 引用数: h-index:机构:Maples, William论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Div Oncol, Jacksonville, FL 32224 USA Mayo Clin, Coll Med, Dept Oncol, Rochester, MN 55905 USAFitch, Tom论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Dept Hematol Oncol, Scottsdale, AZ USA Mayo Clin, Coll Med, Dept Oncol, Rochester, MN 55905 USAEttinger, David论文数: 0 引用数: 0 h-index: 0机构: Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA Mayo Clin, Coll Med, Dept Oncol, Rochester, MN 55905 USAErlichman, Charles论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Coll Med, Dept Oncol, Rochester, MN 55905 USA Mayo Clin, Coll Med, Dept Oncol, Rochester, MN 55905 USASarkaria, Jann N.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Coll Med, Dept Oncol, Rochester, MN 55905 USA Mayo Clin, Coll Med, Dept Oncol, Rochester, MN 55905 USA
- [37] Final Results of the Phase I/II Trial of Weekly Bortezomib In Combination with Temsirolimus (CCI-779) In Relapsed or Relapsed/Refractory Multiple Myeloma Specifically In Patients Refractory to BortezomibBLOOD, 2010, 116 (21) : 435 - 436Ghobrial, Irene M.论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USAWeller, Edie论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USAVij, Ravi论文数: 0 引用数: 0 h-index: 0机构: Washington Univ, Sch Med, Div Oncol, St Louis, MO USA Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USAMunshi, Nikhil C.论文数: 0 引用数: 0 h-index: 0机构: VA Boston Healthcare Syst, Boston, MA USA Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USABanwait, Ranjit论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USARourke, Meghan论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USASchlossman, Robert L.论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USALaubach, Jacob P.论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USAJakubowiak, Andrzej J.论文数: 0 引用数: 0 h-index: 0机构: Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USALeduc, Renee论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USAChuma, Stacey论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USAKunsman, Janet论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USADollard, Akari M.论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USAWarren, Diane论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USAHarris, Brianna论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USAPoon, Tiffany论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USASam, Amy论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USARodig, Scott J.论文数: 0 引用数: 0 h-index: 0机构: Brigham & Womens Hosp, Boston, MA 02115 USA Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USAAnderson, Kenneth C.论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USARichardson, Paul G.论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
- [38] Phase I pharmacokinetic study of temsirolimus (CCI-779) in patients with advanced malignancies and normal and impaired liver function: An NCI Organ Dysfunction Working Group (ODWG) study.JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)Sarantopoulos, J.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr San Antonio, Inst Drug Dev, Canc Therapy & Res Ctr, San Antonio, TX 78229 USALenz, H.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr San Antonio, Inst Drug Dev, Canc Therapy & Res Ctr, San Antonio, TX 78229 USALoRusso, P.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr San Antonio, Inst Drug Dev, Canc Therapy & Res Ctr, San Antonio, TX 78229 USAShibata, S.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr San Antonio, Inst Drug Dev, Canc Therapy & Res Ctr, San Antonio, TX 78229 USAKummar, S.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr San Antonio, Inst Drug Dev, Canc Therapy & Res Ctr, San Antonio, TX 78229 USAMulkerin, D.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr San Antonio, Inst Drug Dev, Canc Therapy & Res Ctr, San Antonio, TX 78229 USARamanathan, R. K.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr San Antonio, Inst Drug Dev, Canc Therapy & Res Ctr, San Antonio, TX 78229 USAMita, M. M.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr San Antonio, Inst Drug Dev, Canc Therapy & Res Ctr, San Antonio, TX 78229 USAO'Rourke, P.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr San Antonio, Inst Drug Dev, Canc Therapy & Res Ctr, San Antonio, TX 78229 USARemick, S. C.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr San Antonio, Inst Drug Dev, Canc Therapy & Res Ctr, San Antonio, TX 78229 USAGoel, S.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr San Antonio, Inst Drug Dev, Canc Therapy & Res Ctr, San Antonio, TX 78229 USAGutierrez, M.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr San Antonio, Inst Drug Dev, Canc Therapy & Res Ctr, San Antonio, TX 78229 USARamalingam, S. S.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr San Antonio, Inst Drug Dev, Canc Therapy & Res Ctr, San Antonio, TX 78229 USAMurgo, A.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr San Antonio, Inst Drug Dev, Canc Therapy & Res Ctr, San Antonio, TX 78229 USADavies, A. M.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr San Antonio, Inst Drug Dev, Canc Therapy & Res Ctr, San Antonio, TX 78229 USAMani, S.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr San Antonio, Inst Drug Dev, Canc Therapy & Res Ctr, San Antonio, TX 78229 USABoni, J.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr San Antonio, Inst Drug Dev, Canc Therapy & Res Ctr, San Antonio, TX 78229 USAShapiro, M.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr San Antonio, Inst Drug Dev, Canc Therapy & Res Ctr, San Antonio, TX 78229 USAIvy, S. P.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr San Antonio, Inst Drug Dev, Canc Therapy & Res Ctr, San Antonio, TX 78229 USATakimoto, C. H.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr San Antonio, Inst Drug Dev, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA
- [39] A phase I and pharmacological study of CCI-779, a rapamycin ester cell cycle inhibitor.ANNALS OF ONCOLOGY, 2000, 11 : 133 - 133Hidalgo, M论文数: 0 引用数: 0 h-index: 0机构: Wyeth Ayerst Res, Radnor, PA USARowinsky, E论文数: 0 引用数: 0 h-index: 0机构: Wyeth Ayerst Res, Radnor, PA USAErlichman, C论文数: 0 引用数: 0 h-index: 0机构: Wyeth Ayerst Res, Radnor, PA USADrengler, R论文数: 0 引用数: 0 h-index: 0机构: Wyeth Ayerst Res, Radnor, PA USAMarshall, B论文数: 0 引用数: 0 h-index: 0机构: Wyeth Ayerst Res, Radnor, PA USAMarks, R论文数: 0 引用数: 0 h-index: 0机构: Wyeth Ayerst Res, Radnor, PA USAEdwards, T论文数: 0 引用数: 0 h-index: 0机构: Wyeth Ayerst Res, Radnor, PA USABoni, J论文数: 0 引用数: 0 h-index: 0机构: Wyeth Ayerst Res, Radnor, PA USADukart, G论文数: 0 引用数: 0 h-index: 0机构: Wyeth Ayerst Res, Radnor, PA USABuckner, J论文数: 0 引用数: 0 h-index: 0机构: Wyeth Ayerst Res, Radnor, PA USA
- [40] Phase I/II study of vandetanib for patients with recurrent malignant gliomas.JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)Mcnicol, K. A.论文数: 0 引用数: 0 h-index: 0机构: NCI, Neurooncol Branch, NIH, Bethesda, MD 20892 USA NCI, Neurooncol Branch, NIH, Bethesda, MD 20892 USAKreisl, T. N.论文数: 0 引用数: 0 h-index: 0机构: NCI, Neurooncol Branch, NIH, Bethesda, MD 20892 USA NCI, Neurooncol Branch, NIH, Bethesda, MD 20892 USAIwamoto, F. M.论文数: 0 引用数: 0 h-index: 0机构: NCI, Neurooncol Branch, NIH, Bethesda, MD 20892 USA NCI, Neurooncol Branch, NIH, Bethesda, MD 20892 USASul, J.论文数: 0 引用数: 0 h-index: 0机构: NCI, Neurooncol Branch, NIH, Bethesda, MD 20892 USA NCI, Neurooncol Branch, NIH, Bethesda, MD 20892 USAFine, H. A.论文数: 0 引用数: 0 h-index: 0机构: NCI, Neurooncol Branch, NIH, Bethesda, MD 20892 USA NCI, Neurooncol Branch, NIH, Bethesda, MD 20892 USA